Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
AFJK
STRONG SELLAimei Health Technology Co., Ltd · Financial Services · United States · $85M · Avg Vol: $328K/d
COMPANY DESCRIPTION
Aimei Health Technology Co., Ltd is a Chinese aesthetic medical services provider, offering a range of non-surgical and surgical beauty treatments through its clinic network. The company focuses on the burgeoning high-end medical aesthetic market, emphasizing advanced technologies and personalized client experiences. Aimei Health Technology aims to expand its market share by catering to increasing demand for beauty and wellness services in China.
FINANCIAL SUMMARY (USD)
| Year | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|
| Revenue | — | 0 | 0 | — | — |
| EPS | — | 0.80 | 0.17 | -78.7% | 0.15 |
| Shares | 9.0M | 3.2M | 3.2M | -64.9% | 3.2M |
| Debt | — | 0.2M | 2.0M | 788.9% | 2.1M |
| Equity | 69.8M | 72.3M | 8.0M | -66.0% | — |
| Op CF | — | -0.7M | -0.6M | — | -0.4M |
| Inv CF | — | -0.3M | 63.6M | — | — |
| Fin CF | — | 0.4M | -63.0M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Financial Services, ranked by industry match, size, and score similarity. Cross-listings of AFJK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| AFJK | Aimei Health Technology Co., Ltd(you) | $85M | 0 | STRONG SELL |
| PECE | Peace Acquisition Corp | $87M | 5 | STRONG SELL |
| JATT | JATT II Acquisition Corp. | $91M | 4 | STRONG SELL |
| MCAH | Mountain Crest Acquisition 6 Corp. | $90M | 6 | STRONG SELL |
| AMAN | Amanat Acquisition Corp | $98M | 6 | STRONG SELL |
| RACD | Research Alliance Corporation IV | $98M | 6 | STRONG SELL |
| SIMA | SIM Acquisition Corp. I | $90M | 8 | STRONG SELL |
| LPAA | Launch One Acquisition Corp. | $84M | 9 | STRONG SELL |
| PCSC | Perceptive Capital Solutions Corp | $113M | 5 | STRONG SELL |
| BRKH | Burtech Acquisition Corp II | $117M | 4 | STRONG SELL |
Peer medians: ROE 9.6% · P/E 13.5x · Gross margin 100.0%